We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Epigenetic Drug Strategy to Treat Cancer

News   Oct 26, 2018 | Original story from Temple University

 
Epigenetic Drug Strategy to Treat Cancer
 
 
Advertisement
 

RELATED ARTICLES

UK Will Offer Genomic Expertise To Find COVID-19 Virus Variants

News

The UK will offer its world-leading genomics expertise to identify new variants of the virus that causes COVID-19 to countries who do not have the resources to do so.

READ MORE

FDA Approves Vericiguat for Use in Patients With Heart Failure

News

The US Food and Drug Administration (FDA) has approved the cardiovascular drug vericiguat. The drug is a once-daily oral treatment for patients with worsening chronic heart failure.

READ MORE

Biologists Unravel the Mechanism of Break-Induced Replication

News

Break-induced replication (BIR) is a way to solve those problems. In humans, it is employed chiefly to repair breaks in DNA that cannot be fixed otherwise. A new study seeks to tease out BIR’s high risk-reward arrangement by describing for the first time the beginning-to-end sequence in BIR.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE